Under this proposed regime, EU member states would be empowered to issue compulsory licenses, allowing companies—including those not originally holding the IP rights—to manufacture, import, or distribute critical goods. Importantly, the proposal includes safeguards to ensure patent holders are fairly compensated for the use of their intellectual property, aiming to preserve incentives for innovation while prioritizing urgent public needs.
The range of products covered under this regime is broad, encompassing medical devices, vaccines, diagnostics, pharmaceuticals, and key energy technologies deemed essential for crisis management. The regime is designed as a temporary measure, activated only during emergencies, to prevent misuse or the erosion of IP rights beyond necessary situations.
Reactions to the EU’s proposal have been mixed. Public health advocates and consumer organizations have praised the move, highlighting its potential to prevent future shortages of lifesaving equipment and medicines. They argue that public welfare must take precedence over commercial interests in times of crisis. However, some industry representatives and proponents of innovation caution that compulsory licensing may undermine the incentives needed for companies to invest in research and development. They emphasize the importance of clear rules and fair compensation to minimize negative effects on innovation.
Legally, the EU’s plan aligns with existing international frameworks, particularly the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which permits compulsory licensing under certain conditions. What sets the EU’s approach apart is its attempt to create harmonized and transparent rules that apply across all member states, thereby reducing legal uncertainties and enabling quicker, coordinated responses to emergencies.
Currently, the proposal is under review by the European Parliament and the Council. If adopted, it would represent a landmark shift in how intellectual property is managed during emergencies within the EU.
